Cross‐Talk between Oxidative Stress and m6A RNA Methylation in Cancer
Author(s) -
Baishuang Yang,
Qiong Chen
Publication year - 2021
Publication title -
oxidative medicine and cellular longevity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.494
H-Index - 93
eISSN - 1942-0900
pISSN - 1942-0994
DOI - 10.1155/2021/6545728
Subject(s) - oxidative stress , microbiology and biotechnology , reactive oxygen species , rna , biology , rna methylation , cancer cell , methylation , oxidative phosphorylation , gene expression , regulation of gene expression , cancer , gene , biochemistry , genetics , methyltransferase
Oxidative stress is a state of imbalance between oxidation and antioxidation. Excessive ROS levels are an important factor in tumor development. Damage stimulation and excessive activation of oncogenes cause elevated ROS production in cancer, accompanied by an increase in the antioxidant capacity to retain redox homeostasis in tumor cells at an increased level. Although moderate concentrations of ROS produced in cancer cells contribute to maintaining cell survival and cancer progression, massive ROS accumulation can exert toxicity, leading to cancer cell death. RNA modification is a posttranscriptional control mechanism that regulates gene expression and RNA metabolism, and m 6 A RNA methylation is the most common type of RNA modification in eukaryotes. m 6 A modifications can modulate cellular ROS levels through different mechanisms. It is worth noting that ROS signaling also plays a regulatory role in m 6 A modifications. In this review, we concluded the effects of m 6 A modification and oxidative stress on tumor biological functions. In particular, we discuss the interplay between oxidative stress and m 6 A modifications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom